Cardiovascular Biomarkers May Enhance Risk Stratification in Primary Prevention, but Evidence for Routine Clinical Use Remains Limited
Key Recommendations: 2026 ESC Guidelines for the Management of Cardiovascular Disease and Chronic Kidney Disease
World Hepatitis Day: Why Hepatitis B Remains a Global Health Challenge Despite Preventive & Treatment Advances
Comparative efficacy and efficiency profile of some commercially available antacids in the Nigerian pharmaceutical market
